The potential for using external applied energy to rectify or ameliorate @entity85 has been explored for decades. A shock wave is a pressure disturbance: tissue effect is cavitation, producing microtrauma or microfracture and haematoma formation, inducing, as to date is thought, increase in vascularization, increased soft @entity9980 . Anaesthesiological interest in this field is focused in non-union or delayed osseous union, joint @entity2693 or @entity6995 and @entity2738 in adults. Actually, because of the @entity158 associated with high energy extracorporeal shock wave therapy on bones, anaesthesia is necessary, but, since almost all @entity1 have no complaint after treatment, there is no need of postoperative @entity1337 . Therefore, short duration anaesthetic techniques and agents should be preferred. Loco-regional anaesthesia or general anaesthesia are both suitable to the purpose. Fifty @entity1 have been treated nowadays in our Institution with shock wave therapy needing anaesthesia. 18 @entity1 (36%) received general anaesthesia. Since @entity1 's stay in hospital was expected to be short, short duration agents have been used, avoiding those causing unpleasent side effects, first emesis. We used @entity1875 or @entity1937 by continuous infusion, titrated to maintain stable haemodynamics and an appropriate level of anaesthesia. The short duration of action of @entity1875 depends on its rapid elimination, whereas @entity1937 undergoes rapid biotransformation to minimally active metabolites. 32 @entity1 (64%) received regional anaesthesia. We avoided long acting agents or high concentration drugs. @entity616 have been performed with 0.5% hyperbaric @entity1341 ; brachial plexus blocks, @entity616 and an @entity616 have been performed with 0.5-1% @entity3303 or 1% @entity10541 . Shock Wave Therapy has been done during a 3-day hospital stay. With suitable anaesthesiological treatment and preparation, almost all @entity1 could be treated as outpatients or with an overnight hospital stay.

Anaesthesia for shock wave therapy in XXXX : a preliminary report.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity6995 :: ('MESH:D055034', 'Disease') :: ['osteochondrosis'] @entity1937 :: ('MESH:C071741', 'Chemical') :: ['Remifentanil'] @entity10541 :: ('MESH:D008619', 'Chemical') :: ['mepivacaine'] @entity1337 :: ('MESH:D000699', 'Disease') :: ['analgesia'] @entity616 :: ('MESH:D006327', 'Disease') :: ['sciatic-femoral blocks', 'epidural block', 'Spinal blocks'] @entity1341 :: ('MESH:D002045', 'Chemical') :: ['bupivacaine'] @entity3303 :: ('MESH:D008012', 'Chemical') :: ['xylocaine'] @entity1875 :: ('MESH:D015742', 'Chemical') :: ['Propofol'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity85 :: ('MESH:D009140', 'Disease') :: ['musculoskeletal disorders'] @entity2738 :: ('MESH:D005271', 'Disease') :: ['femoral head necrosis'] @entity9980 :: ('MESH:C562735', 'Disease') :: ['callus and faster enchondral ossification'] @entity2693 :: ('MESH:C566112', 'Disease') :: ['stiffness']
@entity85 :: (MESH:D009140,Disease) :: ['musculoskeletal disorders']
